Mary J. Laughlin, MD

Original Contribution

The Safety of Autologous Intracoronary Stem Cell Injections
in a Porcine Model of Chronic Myocardial Ischemia

08/01/2008

Robert D. Hoffman , MD, PhD;

Matthew E. Joseph ;

Jason J. Banks ;

Mary J. Laughlin , MD;

Vincent J. Pompili , MD, FACC, FSCAI;

Shyam Bhakta , MD;

Nicholas J. Greco , PhD;

Marcie R. Finney ;

Intracoronary mononuclear cell therapy may lead to angiogenesis in chronic myocardial ischemia. A total of four cell therapy trials in patients with myocardial ischemia not amenable to revascularization have been performed.1 Tse et al....

Intracoronary mononuclear cell...

08/01/2008

Journal of Invasive Cardiology

Addendum

Addendum: The Safety of Autologous Intracoronary Stem Cell Injections in a Porcine Model of Chronic Myocardial Ischemia

08/01/2008

Shyam Bhakta , MD;

Vincent J. Pompili , MD, FACC, FSCAI;

Nicholas J. Greco , PhD;

Marcie R. Finney ;

Paul E. Scheid ;

Robert D. Hoffman , MD, PhD;

Matthew E. Joseph ;

Jason J. Banks ;

Mary J. Laughlin , MD;

The authors of the article cited below, published in the May 2006 issue of the Journal, wish to add the name of Paul E. Scheid to their list of authors whom they inadvertently omitted from the original manuscript. The Safety of Autologous...

The authors of the article cited...

08/01/2008

Journal of Invasive Cardiology